期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

中枢神经系统受累的多发性骨髓瘤10例临床分析 被引量：4

原文传递
导出
摘要 骨髓瘤细胞通常局限在骨髓微环境增殖，中枢神经系统（CNS）受累的髓外病变是多发性骨髓瘤（MM）罕见并发症。为了解CNS受累的MM患者的临床特征及预后，本研究对10例CNS受累的MM患者进行了回顾性分析。
作者 陈海飞 吴天勤 唐杰庆 沈红石 李征洋 侯健
机构地区 解放军第一 第二军医大学长征医院血液科
出处 《中华内科杂志》 CAS CSCD 北大核心 2009年第5期409-410,共2页 Chinese Journal of Internal Medicine
关键词 中枢神经系统受累 多发性骨髓瘤 临床分析 骨髓微环境 骨髓瘤细胞 罕见并发症 髓外病变 临床特征
分类号 R686 [医药卫生—骨科学]
  • 相关文献

参考文献5

  • 1International Myeloma Working Group.Criteria for the classification of monoclonal gammopathies,multiple myeloma and related disorders:a report of the International Myeloma Working Group.Br J Haematol,2003,121:749-757.
  • 2Blade J,Samson D,Reece D,et al.Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation.Myeloma Subcommittee of the EBMT.European Group for Blood and Marrow Transplant.Br J Haematol,1998,102:1115-1123.
  • 3Nieuwenhuizen L,Biesma DH.Central nervous system myelomatosis:review of the literature.Eur J Haematol,2008,80:1-9.
  • 4Fassas AB,Ward S,Muwalla F,et al.Myeloma of the central nervous system:strong association with unfavorable chromosomal abnormalities and other high-risk disease features.Leuk Lymphoma,2004,45:291-300.
  • 5陈海飞,傅卫军,王东星,袁振刚,陈王宝,侯健.40例多发性骨髓瘤伴髓外病变患者的临床特征分析[J].中华血液学杂志,2007,28(10):655-658. 被引量：16

二级参考文献13

  • 1International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol, 2003, 121 : 749-757.
  • 2Blade J, Samson D, Reece D, et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol, 1998,102 : 1115-1123.
  • 3Uppal HS, Harrison P. Extramedullary plasmaeytoma of the larynx presenting with upper airway obstruction in a patient with long-standing IgD myeloma. J Laryngol Otol, 2001,115:745-746.
  • 4Rosinol L, Cibeira MT, Blade J, et al. Extramedullary multiple myeloma escapes the effect of thalidomide. Haematologica, 2004,89: 832-836.
  • 5Garcia-Sanz R, Orfao A, Gonzalez M, et al. Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy and cytogenetic characteristics. Blood, 1999,93 : 1032-1037.
  • 6Damaj G, Mohty M, Vey N,et al. Features of extramedullary and extraosseous multiple myeloma a report of 19 patients from a single center. Eur J Haematol,2004, 73 : 402-406.
  • 7Giampaolo T, Federica C, Maurizio Z, et al. Clinical and biological features of multiple myeloma involving the gastrointestinal system. Haematologiea, 2006, 91:964-967.
  • 8Fassas AB, Ward S, Muwalla F,et al. Myeloma of the central nervous system: strong association with unfavorable chromosomal abnormalities and other high-risk disease features. Leuk Lymphoma, 2004, 45:291-300.
  • 9Chombart B, Lemoussu LG, Esehard JP,et al. Factors useful for predicting survival of myeloma patients in everyday practice. A 10-year study of 148 patients older than 55 years. Joint Bone Spine,2005, 72:544-549.
  • 10Raanani P, Shpilberg O, Ben-Bassat I. Extramedullary disease and targeted therapies for hematological malignancies-is the association real? Ann Oncol, 2007,18:7-12.

共引文献15

同被引文献29

  • 1任志宏,李建勇,盛瑞兰.多发性骨髓瘤合并肾衰竭的临床研究进展[J].白血病．淋巴瘤,2004,13(3):186-188. 被引量：4
  • 2吴冠宇,李建勇.多参数流式细胞术检测多发性骨髓瘤免疫表型及意义[J].国外医学（输血及血液学分册）,2005,28(1):61-63. 被引量：3
  • 3葛祥花,隋金财,刘景玲,孙桂珍.多发性骨髓瘤血清β_2-MG及LDH检测的临床意义[J].白血病．淋巴瘤,2006,15(2):124-125. 被引量：5
  • 4Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival [ J ]. Cancer, 1975,36(3) : 842-854.
  • 5Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma [ J]. Mayo Clin Proc, 2003,78:21-33.
  • 6Dispenzieri A, Lacy MQ, Greipp PR. Multiple myelma. In:Greer JP ,Foerster J,Lukens JN ,et al, eds. Wintrobe's clinical hematology [ M ]. 11th ed. Philadephia: Lippineott Williams & Wilkins ,2004. 2538-2636.
  • 7Jagannath S, Tricot G, Barlogie B. Autotransplants in multiple myeloma: pushing the envelope [ J]. Hemat Oncol Clin North Am, 1997,11:363-381.
  • 8Bartlett JB, Dredge K, Dalgleish AG. The evolution of thalidomide and its IMiD derivatives as anticancer agents[ J]. Nat Rev Cancer,2004, 4:314-322.
  • 9Samson D, Singer C. Multiple myeloma. Clin Med, 2001,1: 365-370.
  • 10Chamberlain MC, Glantz M. Myelomatous meningitis. Cancer, 2008, 112: 1562-1567.

引证文献4

二级引证文献6

中华内科杂志
2009年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部